Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
暂无分享，去创建一个
J. Burke | K. Kolibaba | I. Flinn | R. Van der Jagt | M. Hertzberg | B. Kahl | D. Simpson | M. Munteanu | M. Craig | Y. Kwan | S. Issa | P. Wood | Doreen M. Hallman | Ling Chen | R. Clementi | T. Hawkins | D. Macdonald | D. Hallman